alexa The Effect of Weight Losing to Benign Prostate Hyperplasia Patients with Metabolic Syndrome | OMICS International | Abstract
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

The Effect of Weight Losing to Benign Prostate Hyperplasia Patients with Metabolic Syndrome

LU Yong1*, LI Jin-lian2, WU Yan-lin3, PANG Shu-guang1, HU Su1 and JIANG-Qiang1
1Department of Endocrinology, Jinan Central Hospital, Jinan, China
2Department of Neurology, The Fifth People’s Hospital of Jinan, Jinan, China
33Department of Urology, Jinan Central Hospital, Jinan, China
Corresponding Author : LU Yong
Department of endocrinology
Jinan central hospital
Jinan 250013, China
E-mail: [email protected]
Received october 02, 2012; Accepted November 26, 2012; Published November 28, 2012
Citation: Yong L, Jin-Lian L, Yan-Lin W, Shu-Guang P, Su H, et al. (2012) The Effect of Weight Losing to Benign Prostate Hyperplasia Patients with Metabolic Syndrome. J Obes Wt Loss Ther 2:151. doi:10.4172/2165-7904.1000151
Copyright: © 2012 Yong L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Objective: To explore the effect of weight losing to benign prostate hyperplasia patients with metabolic syndrome.

Methods: We chose 82 benign prostate hyperplasia patients who came for treatment in 2010 and divided them into group A and group B randomly. We measured body weight, height, and calculated body mass index, and we also measured blood pressure, fasting plasma glucose, total triglycerides, high density lipoprotein cholesterol, prostate specific antigen, prostate volume, and international prostate syndrome score. Group A received standard treatment; Group B got extra weight losing direction besides standard treatment. After six months, we compared the abovementioned measurements.
Results: BMI, prostate volume, international prostate syndrome score and total triglycerides in group B are significant lower than group A.
Conclusions On the basis of standard treatment metabolic syndrome patients with benign prostate hyperplasia
can benefit more from weight losing.

Keywords

Top